Incident heart failure and myocardial infarction in sodium‐glucose cotransporter‐2 vs. dipeptidyl peptidase‐4 inhibitor users

Abstract Aims This study aimed to compare the rates of major cardiovascular adverse events in sodium‐glucose cotransporter‐2 inhibitors (SGLT2I) and dipeptidyl peptidase‐4 inhibitors (DPP4I) users in a Chinese population. SGLT2I and DPP4I are increasingly prescribed for type 2 diabetes mellitus pati...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Abraham Ka Chung Wai, Tong Liu, Ying Liu, Dong Chang, Wing Tak Wong, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng Zhang, Gary Tse
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2022-04-01
Col·lecció:	ESC Heart Failure
Matèries:	Sodium‐glucose co‐transporter Heart failure Myocardial infarction Diabetes mellitus
Accés en línia:	https://doi.org/10.1002/ehf2.13830
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!